NIPT Test in Gateshead
Fast and accurate non-invasive prenatal testing now available in Gateshead. DNA-based blood screening with results in 3-5 working days. Choose from three tiers (Standard, Advance or Absolute) based on the depth of screening you'd like.
From £265 (Standard, Advance & Absolute tiers)
What's Included
Comprehensive non-invasive prenatal screening with fast results
Detection of three major chromosomal conditions
Precise gender confirmation included
No GP referral required
Early pregnancy scan included
Complimentary black & white pictures
Results in 3-5 working days
Non-invasive blood test
99%+ accuracy rate
Suitable from 10 weeks gestation
Three NIPT tiers to choose from
All tiers screen for the three major chromosomal conditions and offer optional gender determination. Higher tiers expand the panel to additional sex-chromosome and microdeletion conditions. Each tier is available as a blood test alone or combined with an early pregnancy scan.
NIPT Standard
From 10 weeks
- Trisomy 21 (Down syndrome)
- Trisomy 18 (Edwards syndrome)
- Trisomy 13 (Patau syndrome)
- Optional gender confirmation
NIPT Advance
From 10 weeks
- Everything in Standard
- Sex-chromosome conditions (Turner, Klinefelter, etc.)
- Optional gender confirmation
- Wider screening panel
NIPT Absolute
From 10 weeks
- Everything in Advance
- Selected microdeletion syndromes
- Most comprehensive panel we offer
- Optional gender confirmation
What's included in each tier
Compare the screening panel side by side. Higher tiers expand to additional sex chromosome conditions and a broad microdeletion screen.
| What's screened | Standard | Advance | Absolute |
|---|---|---|---|
| Trisomy 21 (Down syndrome) | ✓ | ✓ | ✓ |
| Trisomy 18 (Edwards syndrome) | ✓ | ✓ | ✓ |
| Trisomy 13 (Patau syndrome) | ✓ | ✓ | ✓ |
| Optional gender determination | ✓ | ✓ | ✓ |
| Sex chromosome aneuploidies (XO, XXY, XYY, XXX) | — | ✓ | ✓ |
| 60 microdeletion syndromes | — | — | ✓ |
| Suitable for twin pregnancies | ✓ | — | — |
← Swipe horizontally to compare all tiers →
Looking for gender determination only?
Our Early Gender Blood Test uses the same DNA technology focused specifically on baby's sex, from 7 weeks, £125 (or £175 with an early pregnancy scan).
What is NIPT?
NIPT (Non-Invasive Prenatal Testing) is an advanced DNA-based blood screening that analyses fetal DNA fragments in maternal blood to predict the risk of chromosomal conditions.
The test offers enhanced accuracy compared to traditional screening methods, with significantly reduced false-positive results. This minimises the need for invasive procedures like amniocentesis. See our 12-week milestone guide for context on first-trimester screening options, or our private vs NHS comparison guide for how NIPT compares to the NHS combined test.
As an added benefit, NIPT also provides optional fetal sex assessment at no additional charge, though if you're only interested in gender, our standalone Early Gender Blood Test from £125 (from 7 weeks) uses similar DNA technology focused specifically on baby's sex.
NIPT is endorsed by leading international professional bodies including the American College of Obstetricians and Gynaecologists (ACOG), the Society for Maternal Fetal Medicine, the American College of Medical Genetics and Genomics, the European Society of Human Genetics and the International Society for Prenatal Diagnosis.
Who can book NIPT?
NIPT is available from 10 weeks of pregnancy onwards and is suitable for most women with singleton or twin pregnancies, whether conception occurred naturally or through IVF. Many women choose to have the test after their dating scan or during the late first or early second trimester.
There are some situations where NIPT may not be suitable or may require specialist advice:
- Pregnancies affected by a vanishing twin, as residual DNA from the demised twin can affect accuracy
- Some triplet or higher-order multiple pregnancies, depending on the laboratory used
- Other specific clinical circumstances that can be discussed during your appointment
The NIPT Process
Your NIPT appointment involves three simple steps:
- Step 1: Early pregnancy scan to confirm dates and viability
- Step 2: Blood test (simple blood draw from your arm)
- Step 3: Receive your results in 3-5 working days
The entire appointment takes approximately 30 minutes. Results are sent directly to you once processed by the laboratory.
Why women choose NIPT
Any pregnant woman from 10 weeks can choose NIPT for higher detection accuracy than the standard NHS combined screening. Specific reasons our patients book privately:
Higher accuracy than NHS combined screening
DNA-based detection above 99% for the common trisomies, with a far lower false-positive rate than the standard first-trimester combined test.
Maternal age 35 or older
Background risk for chromosomal conditions rises with maternal age. NIPT offers reassurance with a single non-invasive blood test, without the risks of amniocentesis.
Avoiding the risks of invasive testing
If there are contraindications for amniocentesis or CVS (such as placenta praevia, miscarriage risk or maternal anxiety), NIPT provides screening information without any risk to the pregnancy.
Previous pregnancy with a chromosomal condition
If a prior pregnancy was affected by Trisomy 21, 18 or 13, NIPT can provide an early, accurate risk assessment for the current pregnancy.
Unusual ultrasound findings
If your dating or 12-week scan shows soft markers suggesting an increased risk of T21, T18 or T13, NIPT can refine that risk with a DNA-level read.
After IVF or recurrent miscarriage
Pregnancies conceived via IVF or following recurrent miscarriage often warrant additional reassurance. NIPT delivers high-confidence screening without any procedural risk.
Am I eligible for NIPT?
NIPT is suitable for the vast majority of pregnancies. Specific medical or pregnancy-related situations affect eligibility, so speak to our team if you're unsure about your circumstances.
| Factor | Details | Eligible? |
|---|---|---|
| Gestational age at draw | 10 weeks or later | Yes |
| Less than 10 weeks | No | |
| Number of fetuses | Singleton or twin (NIPT Standard only for twins) | Yes |
| Triplets or higher-order | No | |
| Vanishing twin syndrome | Developmental arrest finished 8+ weeks before sample, before pregnancy week 8 | Yes |
| Less than 8 weeks since developmental arrest | No | |
| Developmental arrest occurred after pregnancy week 8 | No | |
| Heparin or analogues | At least 24-hour pause before blood draw | Yes |
| Less than 24-hour pause | No | |
| History of benign or malignant tumor | No tumor DNA in maternal blood (in remission) | Yes |
| Currently affected by tumor | No | |
| Cellular immunotherapy with exogenous DNA | At least 4-week gap since last therapy | Yes |
| Less than 4 weeks since last therapy | No | |
| Human serum albumin therapy | At least 4-week gap since last therapy | Yes |
| Less than 4 weeks since last therapy | No | |
| Blood transfusion | At least 1-year gap since last transfusion | Yes |
| Less than 1 year since last transfusion | No | |
| Stem cell therapy | Any history of stem cell therapy | No |
| Organ transplant (maternal) | Any history of maternal organ transplant | No |
| Abnormal maternal karyotype | Inversion, translocation, deletion, duplication or mosaicism (requires pre-test consultation) | No |
← Swipe horizontally to see the full table →
What NIPT screens for
NIPT screens for chromosomal conditions across three groups. Coverage widens with each tier.
Common trisomies
All tiersTrisomy 21
Down Syndrome
Trisomy 18
Edwards Syndrome
Trisomy 13
Patau Syndrome
Sex chromosome aneuploidies
Advance & AbsoluteTurner
Monosomy X
Klinefelter
XXY syndrome
Jacob's
XYY syndrome
Triple X
XXX syndrome
60 microdeletion syndromes
Absolute onlyView the full list of 60 syndromes covered
- Androgen insensitivity syndrome (AIS)
- Angelman / Prader-Willi syndrome
- Bannayan-Riley-Ruvalcaba syndrome (BRRS)
- Branchiootorenal dysplasia (BOR) / Melnick-Fraser syndrome
- Cat eye syndrome (CES)
- Chromosome 10q deletion syndrome
- Chromosome 10q22.3-q23.31 microdeletion
- Chromosome 18p deletion syndrome
- Chromosome 18q deletion syndrome
- Cornelia de Lange syndrome (CDLS)
- Cowden syndrome (CD)
- Cri du Chat (5p deletion) syndrome
- Dandy-Walker syndrome (DWS)
- DiGeorge syndrome type 2 (DGS2)
- Distal arthrogryposis type 2B (DA2B)
- Duchenne and Becker muscular dystrophy (DMD/BMD)
- Dyggve-Melchior-Clausen syndrome (DMC)
- Feingold syndrome
- Holoprosencephaly type 1 (HPE1)
- Holoprosencephaly type 4 (HPE4)
- Holoprosencephaly type 6 (HPE6)
- Jacobsen syndrome
- Langer-Giedion syndrome (LGS)
- Leukodystrophy with 11q14.2-q14.3
- Mental retardation, X-linked growth hormone deficiency (MRGH)
- Microphthalmia, syndromic type 6, pituitary hypoplasia
- Microphthalmia with linear skin defects
- Monosomy 9p syndrome
- Orofaciodigital syndrome
- Panhypopituitarism, X-linked
- Potocki-Lupski syndrome (17p11.2 duplication)
- Prader-Willi-like syndrome (SIM1)
- Rieger syndrome type 1 (RIEG1)
- Saethre-Chotzen syndrome (SCS)
- Sensorineural deafness and male infertility
- Smith-Magenis syndrome
- Split-hand/foot malformation type 3 (SHFM3)
- Split-hand/foot malformation type 5 (SHFM5)
- Congenital diaphragmatic hernia (HCD/DIH)
- Trichorhinophalangeal syndrome type I (TRPSI)
- Van der Woude syndrome (VWS)
- WAGR syndrome and aniridia II
- Wilms tumor 1 (WT1)
- X-linked lymphoproliferative syndrome (XLP)
- Xp11.22-p11.23 microduplication syndrome
- 1p36 microdeletion syndrome
- 1q41-q42 microdeletion syndrome
- 2q33.1 deletion / Glass syndrome
- 5q21.1-q31.2 deletion syndrome
- 8p23.1 deletion syndrome
- 8p23.1 duplication syndrome
- 11q11-q13.3 duplication syndrome
- 12q14 microdeletion syndrome
- 14q11-q22 deletion syndrome
- 15q26 overgrowth syndrome
- 16p11.2-p12.2 microdeletion syndrome
- 16p11.2-p12.2 microduplication syndrome
- 17q21.31 deletion syndrome
- 17q21.31 duplication syndrome
Statistically proven accuracy
Per-condition sensitivity and specificity from a validation study of over 146,000 pregnancies.
| Condition | Sensitivity | Specificity |
|---|---|---|
| Common trisomies | ||
| Trisomy 21 (Down syndrome) | 99.17% | 99.95% |
| Trisomy 18 (Edwards syndrome) | 98.24% | 99.95% |
| Trisomy 13 (Patau syndrome) | >99.9% | 99.96% |
| Copy number variants (microdeletions) | ||
| CNV >10 Mb | >99.9% | 99.97% |
| CNV <10 Mb | >99.9% | 99.86% |
| Sex chromosome aneuploidies | ||
| Turner syndrome (XO) | >99.9% | 99.6% |
| Klinefelter syndrome (XXY) | >99.9% | 99.6% |
| Jacob's syndrome (XYY) | >99.9% | 99.6% |
| Triple X syndrome (XXX) | >99.9% | 99.6% |
| Fetal sex determination | ||
| Fetal sex (gender) | 99.53% | 99.20% |
Validation study: 146,958 pregnancies · Resample rate ~2.18% · No-call rate ~0.069%
Frequently Asked Questions
Book Your NIPT Test
Get peace of mind with our advanced prenatal screening. Our friendly team is ready to welcome you to our Gateshead clinic.
Book NIPT Test